ＩＣＨ（医薬品規制調和国際会議）が新しくなりました。 ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000102412.htmlＩＣＨ（医薬品規制調和国際会議）が新しくなりました。 ｜報道発表資料｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the reorganization of the ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use). On October 23, 2015, a new ICH organization was established as a Swiss-based international non-profit entity. The new organization comprises a General Assembly, Management Committee, and expert working groups. Member organizations include regulatory authorities from Japan, the US, EU, Switzerland, and Canada, along with pharmaceutical industry associations. The WHO and IFPMA participate as observers. Japan's PMDA serves as Vice-Chair of the General Assembly and holds veto rights on major decisions. The ICH continues promoting international regulatory harmonization through guideline development for drug approval and post-market safety measures.
